Wake Forest University Baptist Medical Center – Developmental Therapeutics Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “Wake Forest University Baptist Medical Center – Developmental Therapeutics Review – Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
Reasons to buy
Summary
Global Market Direct’s pharmaceuticals report, “Wake Forest University Baptist Medical Center – Developmental Therapeutics Review – Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Wake Forest University Baptist Medical Center – Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Wake Forest University Baptist Medical Center human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Wake Forest University Baptist Medical Center with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Wake Forest University Baptist Medical Center’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Wake Forest University Baptist Medical Center’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Wake Forest University Baptist Medical Center in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Wake Forest University Baptist Medical Center’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Wake Forest University Baptist Medical Center.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Wake Forest University Baptist Medical Center and identify potential opportunities in those areas.
Wake Forest University Baptist Medical Center Snapshot
Key Information
Key Facts
Wake Forest University Baptist Medical Center – Research and Development Overview
Key Therapeutic Areas
Wake Forest University Baptist Medical Center – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Wake Forest University Baptist Medical Center – Pipeline Products Glance
Wake Forest University Baptist Medical Center – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Wake Forest University Baptist Medical Center Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Wake Forest University Baptist Medical Center–Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Wake Forest University Baptist Medical Center – Drug Profiles
Carboplatin + Paclitaxel + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
methylphenidate hydrochloride
Product Description
Mechanism of Action
R&D Progress
Procrit + Carboplatin + Paclitaxel + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Carboplatin + Irinotecan + Thalidomide
Product Description
Mechanism of Action
R&D Progress
Irinotecan + Gemcitabine + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
procarbazine hydrochloride + thalidomide
Product Description
Mechanism of Action
R&D Progress
Temozolomide + Thalidomide + Radiation theraphy
Product Description
Mechanism of Action
R&D Progress
Thalidomide + Procarbazine
Product Description
Mechanism of Action
R&D Progress
Benzylquinolone Carboxylic Acid
Product Description
Mechanism of Action
R&D Progress
Wake Forest University Baptist Medical Center – Pipeline Analysis
Wake Forest University Baptist Medical Center – Pipeline Products by Therapeutic Class
Wake Forest University Baptist Medical Center Pipeline Products By Target
Wake Forest University Baptist Medical Center – Pipeline Products by Route of Administration
Wake Forest University Baptist Medical Center – Pipeline Products by Molecule Type
Wake Forest University Baptist Medical Center – Locations And Subsidiaries
Head Office
Recent Developments
Jan 12, 2010: New Compound Improves Cognitive Decline, Symptoms Of Alzheimer’s Disease In Rodents
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 37
LIST OF TABLES
Wake Forest University Baptist Medical Center – Pipeline by Therapy Area and Indication, 2010
Wake Forest University Baptist Medical Center – Pipeline by Stage of Development, 2010
Wake Forest University Baptist Medical Center – Monotherapy Products in Pipeline, 2010
Wake Forest University Baptist Medical Center – Combination Treatment Modalities in Pipeline, 2010
Wake Forest University Baptist Medical Center – Phase III, 2010
Wake Forest University Baptist Medical Center - Phase II, 2010
Wake Forest University Baptist Medical Center - Pipeline By Therapeutic Class, 2010
Wake Forest University Baptist Medical Center - Pipeline By Target, 2010
Wake Forest University Baptist Medical Center – Pipeline By Route of Administration, 2010
Wake Forest University Baptist Medical Center – Pipeline By Molecule Type, 2010 32
LIST OF FIGURES
Wake Forest University Baptist Medical Center – Pipeline by Therapy Area and Indication, 2010
Wake Forest University Baptist Medical Center – Pipeline by Stage of Development, 2010
Wake Forest University Baptist Medical Center – Monotherapy Products in Pipeline, 2010
Wake Forest University Baptist Medical Center – Combination Treatment Modalities in Pipeline, 2010
Wake Forest University Baptist Medical Center – Pipeline By Therapeutic Class, 2010
Wake Forest University Baptist Medical Center - Pipeline By Target, 2010
Wake Forest University Baptist Medical Center – Pipeline By Route of Administration, 2010
Wake Forest University Baptist Medical Center – Pipeline By Molecule Type, 2010 32
Key Information
Key Facts
Wake Forest University Baptist Medical Center – Research and Development Overview
Key Therapeutic Areas
Wake Forest University Baptist Medical Center – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Wake Forest University Baptist Medical Center – Pipeline Products Glance
Wake Forest University Baptist Medical Center – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Wake Forest University Baptist Medical Center Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Wake Forest University Baptist Medical Center–Early Stage Pipeline Products
Discovery Products/Combination Treatment Modalities
Wake Forest University Baptist Medical Center – Drug Profiles
Carboplatin + Paclitaxel + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
methylphenidate hydrochloride
Product Description
Mechanism of Action
R&D Progress
Procrit + Carboplatin + Paclitaxel + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
Carboplatin + Irinotecan + Thalidomide
Product Description
Mechanism of Action
R&D Progress
Irinotecan + Gemcitabine + Radiation Therapy
Product Description
Mechanism of Action
R&D Progress
procarbazine hydrochloride + thalidomide
Product Description
Mechanism of Action
R&D Progress
Temozolomide + Thalidomide + Radiation theraphy
Product Description
Mechanism of Action
R&D Progress
Thalidomide + Procarbazine
Product Description
Mechanism of Action
R&D Progress
Benzylquinolone Carboxylic Acid
Product Description
Mechanism of Action
R&D Progress
Wake Forest University Baptist Medical Center – Pipeline Analysis
Wake Forest University Baptist Medical Center – Pipeline Products by Therapeutic Class
Wake Forest University Baptist Medical Center Pipeline Products By Target
Wake Forest University Baptist Medical Center – Pipeline Products by Route of Administration
Wake Forest University Baptist Medical Center – Pipeline Products by Molecule Type
Wake Forest University Baptist Medical Center – Locations And Subsidiaries
Head Office
Recent Developments
Jan 12, 2010: New Compound Improves Cognitive Decline, Symptoms Of Alzheimer’s Disease In Rodents
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer 37
LIST OF TABLES
Wake Forest University Baptist Medical Center – Pipeline by Therapy Area and Indication, 2010
Wake Forest University Baptist Medical Center – Pipeline by Stage of Development, 2010
Wake Forest University Baptist Medical Center – Monotherapy Products in Pipeline, 2010
Wake Forest University Baptist Medical Center – Combination Treatment Modalities in Pipeline, 2010
Wake Forest University Baptist Medical Center – Phase III, 2010
Wake Forest University Baptist Medical Center - Phase II, 2010
Wake Forest University Baptist Medical Center - Pipeline By Therapeutic Class, 2010
Wake Forest University Baptist Medical Center - Pipeline By Target, 2010
Wake Forest University Baptist Medical Center – Pipeline By Route of Administration, 2010
Wake Forest University Baptist Medical Center – Pipeline By Molecule Type, 2010 32
LIST OF FIGURES
Wake Forest University Baptist Medical Center – Pipeline by Therapy Area and Indication, 2010
Wake Forest University Baptist Medical Center – Pipeline by Stage of Development, 2010
Wake Forest University Baptist Medical Center – Monotherapy Products in Pipeline, 2010
Wake Forest University Baptist Medical Center – Combination Treatment Modalities in Pipeline, 2010
Wake Forest University Baptist Medical Center – Pipeline By Therapeutic Class, 2010
Wake Forest University Baptist Medical Center - Pipeline By Target, 2010
Wake Forest University Baptist Medical Center – Pipeline By Route of Administration, 2010
Wake Forest University Baptist Medical Center – Pipeline By Molecule Type, 2010 32
